Relief Therapeutics (Switzerland) Insiders
| RLF Stock | CHF 5.10 0.06 1.19% |
Relief Therapeutics employs about 10 people. The company is managed by 13 executives with a total tenure of roughly 24 years, averaging almost 1.0 years of service per executive, having 0.77 employees per reported executive. Recap of Relief Therapeutics' management performance can provide insight into the venture performance.
| Jeremy CPA Insider CFO Officer |
| David McCullough Insider Sr Access |
Relief |
Relief Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.1217) % which means that it has lost $0.1217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3257) %, meaning that it generated substantial loss on money invested by shareholders. Relief Therapeutics' management efficiency ratios could be used to measure how well Relief Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Relief Therapeutics Workforce Comparison
Relief Therapeutics Holding is rated fourth in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 887. Relief Therapeutics claims roughly 10.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
Relief Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Relief Therapeutics Price Series Summation is a cross summation of Relief Therapeutics price series and its benchmark/peer.
Relief Therapeutics Notable Stakeholders
A Relief Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Relief Therapeutics often face trade-offs trying to please all of them. Relief Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Relief Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jeremy CPA | CFO Officer | Profile | |
| David McCullough | Sr Access | Profile | |
| DPhil MBA | Chief Officer | Profile | |
| Jeremy Meinen | Chief Admin | Profile | |
| Dorian Bevec | Chief Lifescience | Profile | |
| Drew CroninFine | Exec Marketing | Profile | |
| Christopher Wick | Sr Sales | Profile | |
| Paolo Galfetti | COO Director | Profile | |
| Marco Marotta | Chief Officer | Profile | |
| Jack Weinstein | Treasurer CFO | Profile | |
| Anthony Kim | Sr Operations | Profile | |
| Jack MBA | Chief Officer | Profile | |
| Serene MPH | VP Medicine | Profile |
About Relief Therapeutics Management Performance
The success or failure of an entity such as Relief Therapeutics often depends on how effective the management is. Relief Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Relief management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Relief management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. RELIEF THERAPEUTICS operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange. It employs 10 people.
Please note, the imprecision that can be found in Relief Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Relief Therapeutics Holding. Check Relief Therapeutics' Beneish M Score to see the likelihood of Relief Therapeutics' management manipulating its earnings.
Relief Therapeutics Workforce Analysis
Traditionally, organizations such as Relief Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Relief Therapeutics within its industry.Relief Therapeutics Manpower Efficiency
Return on Relief Therapeutics Manpower
| Revenue Per Employee | 332.1K | |
| Revenue Per Executive | 255.5K | |
| Net Loss Per Employee | 3.5M | |
| Net Loss Per Executive | 2.7M |
Additional Tools for Relief Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.